Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China
NCT04328675 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4752
Last updated 2020-04-28
Summary
A multi-center registration study of natural history and clinical characteristics of ALS in mainland China
Conditions
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Principal Investigators
-
Dongsheng Fan, MD, PhD · Peking University Third Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-20
- Primary Completion
- 2023-03-20
- Completion
- 2023-03-20
Countries
- China
Study Locations
More Related Trials
-
Pediatric Spinal Muscular Atrophy (SMA) China Registry
NCT05042921 ·Status: ACTIVE_NOT_RECRUITING
-
A Registered Cohort Study on SMA
NCT04010604 ·Status: RECRUITING
-
A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00445172 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.
NCT05852418 ·Status: RECRUITING
-
Application of Motor Unit Estimation Index in Amyotrophic Lateral Sclerosis and Related Diseases
NCT04956822 ·Status: UNKNOWN
-
The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis
NCT01494480 ·Status: UNKNOWN ·Phase: PHASE2
-
Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry
NCT07143656 ·Status: ACTIVE_NOT_RECRUITING
-
Correlation Between Intestinal Microflora Metabolites and Amyotrophic Lateral Sclerosis
NCT04948346 ·Status: COMPLETED
-
Adult Spinal Muscular Atrophy (SMA) China Registry
NCT05618379 ·Status: ACTIVE_NOT_RECRUITING
-
Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis
NCT03085706 ·Status: COMPLETED ·Phase: NA
-
Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response
NCT00753571 ·Status: UNKNOWN ·Phase: PHASE2
-
Perception of Unpleasant Sensations During Study Procedures in ALS Patients
NCT06325865 ·Status: COMPLETED
-
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis
NCT06351735 ·Status: NOT_YET_RECRUITING
-
Amyotrophic Lateral Sclerosis Registry in Thailand
NCT07175935 ·Status: RECRUITING
-
A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00444613 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis
NCT02383654 ·Status: COMPLETED ·Phase: PHASE1
-
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
NCT00004457 ·Status: UNKNOWN
-
potentiALS - Quality of Life Among Patients With Amyotrophic Lateral Sclerosis
NCT06441448 ·Status: RECRUITING
-
Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis
NCT06181526 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Neurofilament Light Chain in Amyotrophic Lateral Sclerosis
NCT06201650 ·Status: RECRUITING
-
Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients
NCT05423678 ·Status: NOT_YET_RECRUITING
-
Staging System in Amyotrophic Lateral Sclerosis
NCT04858555 ·Status: UNKNOWN
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Muscular Biomarkers in Amyotrophic Lateral Sclerosis
NCT02670226 ·Status: COMPLETED ·Phase: NA